Daily Clinical Briefing · Educational reading for healthcare professionals
Light–dark comparison and associated signs help separate benign anisocoria from neurological emergencies.
If anisocoria worsens in bright light, the larger pupil is failing to constrict; if it worsens in darkness, the smaller pupil is failing to dilate.
New anisocoria is a bedside localisation problem before it is a diagnosis. The useful first step is not deciding whether the larger pupil looks abnormal, but comparing both pupils in the same ambient light and then asking how the difference changes in bright and dark conditions.
If inequality increases in bright light, the larger pupil is failing to constrict, pointing to parasympathetic dysfunction. If it becomes greater in darkness, the smaller pupil is failing to dilate, pointing to sympathetic dysfunction. That distinction narrows what should be examined next.
A large poorly reactive pupil with ptosis and abnormal eye movements raises concern for third nerve palsy, and pupil sparing does not reliably exclude an aneurysm. A small pupil with delayed dilation in darkness and subtle ptosis suggests Horner's syndrome. If that is new and accompanied by headache or neck pain on the same side, internal carotid artery dissection becomes a concern. Reduced facial sweating may be absent.
Context becomes particularly important after head injury. A new fixed dilated pupil accompanied by vomiting or a falling Glasgow Coma Scale score can reflect expanding intracranial pathology and progressive third-nerve compression. Repeat the ABCDE assessment, avoid hypoxia and hypotension, and expedite imaging and neurosurgical care. Short-term controlled hyperventilation has a rescue role when herniation is imminent, but routine hyperventilation reduces cerebral blood flow.
The same pupil finding means something different after cardiac arrest. Fixed dilated pupils during arrest or immediately after return of circulation should not determine neurological prognosis. At 72 hours, bilaterally fixed dilated pupils are highly specific but poorly sensitive for poor outcome when light responses are assessed accurately and confounders and ocular injury are excluded. Even then, they belong within a multimodal assessment rather than standing alone.
Serial examination matters because the direction of change carries clinical information. Record each pupil separately, include size and reactivity, and document when the change occurred alongside the neurological examination. A new pupil abnormality with falling consciousness should trigger urgent reassessment and definitive care rather than simply another pupil measurement.
Easy bruising and thrombocytopenia should first trigger exclusion of dangerous causes, then a structured distinction between underproduction, peripheral destruction and sequestration; in transplant recipients, recurrent post-transplant lymphoproliferative disorder can trigger immune thrombocytopenia despite negative blood Epstein–Barr virus testing.
Progressive gait change, cognitive decline and urinary dysfunction in older adults can signal idiopathic normal pressure hydrocephalus, but ventricular enlargement alone is insufficient; timed gait assessment before and after cerebrospinal fluid drainage, including delayed response, helps select patients for shunting.
Safer clinical artificial intelligence use depends on recognising incorrect outputs, potential reuse of sensitive information and environmental costs; training should address these risks while acknowledging that electronic records, workflows and patient encounters differ across healthcare systems.
The HARVEST trial finds no survival benefit from rifampicin 35 mg/kg compared with 10 mg/kg in tuberculous meningitis, with possible harm; increased dexamethasone metabolism offers one proposed mechanism and supports retaining standard rifampicin dosing.
Pupil size and reactivity must be interpreted in context: light–dark differences help localise anisocoria, evolving changes can signal intracranial deterioration, and fixed pupils after cardiac arrest require delayed, confounder-free multimodal prognostication rather than premature conclusions.
Residency over-application is fuelled by uncertainty about competitiveness and programme fit, while preference signals, application caps and interview formats create uneven trade-offs; clearer programme information and properly resourced holistic review may improve decision-making without assuming one uniform solution.
Renaissance medicine mixed humoral theory, household knowledge, apprenticeship and emerging professional regulation, while patient accounts, annotated remedy books, anatomical observation and repeated surgical experience show how practitioners judged benefit, developed expertise and sometimes caused harm.
When pupils are unequal, record each side separately in the same ambient light, then compare bright and dim conditions before deciding which pupil is abnormal. Repeat and time pupil assessments alongside the Glasgow Coma Scale. Treat a new pupil change with falling consciousness as deterioration requiring ABCDE reassessment, prevention of hypoxia and hypotension, and urgent imaging and neurosurgical care.
An alert patient has a larger left pupil, and the difference between the pupils becomes more marked in bright light. Which functional abnormality best explains this pattern?
The left pupil is failing to constrict, indicating left parasympathetic dysfunction. Sympathetic dysfunction instead produces a smaller abnormal pupil whose inequality becomes more obvious in darkness.
An older adult has progressive gait difficulty, cognitive change, urinary symptoms and ventricular enlargement. A large-volume lumbar puncture produces no clear gait improvement during early same-day testing. Does this exclude idiopathic normal pressure hydrocephalus or benefit from shunting?
No. Gait improvement may peak 24–48 hours after drainage, so an early equivocal response should not automatically end the assessment. Extended lumbar drainage with repeated gait measurements can be considered when uncertainty remains.
A randomised trial of tuberculous meningitis finds that rifampicin 35 mg/kg improves central nervous system drug exposure but six-month mortality is 44.6%, compared with 40% using 10 mg/kg. What treatment conclusion follows?
Improved drug penetration does not establish clinical benefit. The trial supports retaining standard-dose rifampicin rather than routinely adopting the higher dose, which shows no survival advantage and a signal of harm.
Daily Clinical Briefings are prepared using ChatGPT Pro from the show notes and educational output for that day’s episodes. Iain Beardsell then checks the briefing for accuracy.
This describes the current briefing process. Item-specific review dates are shown only where documented. The original podcasts remain the sources; MedPod’s briefing is additional educational material.
Read about MedPod’s editorial approach
Report an error or source concern — please include the article title and link, without patient-identifying information.
.svg)